Used in research for neurodegenerative disorders, particularly Alzheimer’s disease. Shows potential in improving cognitive function by modulating synaptic plasticity and enhancing memory. Acts as a selective inhibitor of phosphodiesterase-4D (PDE4D), which plays a role in regulating cyclic AMP levels in brain cells. This mechanism supports neuronal communication and may slow cognitive decline. Investigated for therapeutic use in fragile X syndrome due to its impact on learning and memory pathways. Currently in experimental stages, primarily in preclinical and early clinical trials.